China sales rebound; Europe, Southeast Asia markets strong
ADA, Mich., Feb. 6 /PRNewswire/ -- Alticor Inc. and its subsidiaries reported record sales of more than $7.1 billion for the year ended Dec. 31, 2007, a 12-percent increase over the $6.3 billion recorded in 2006.
Company officials attributed the increase to continued growth of strong Amway markets in Europe, Southeast Asia and Latin America, a rebound in China following the long-awaited establishment of direct selling regulations, and the continuing appeal of the company's consumer product lines. They acknowledged that the increased sales resulted in stronger profits, but the privately held company did not disclose further details.
"Our global business has shown real strength and resiliency this year," said Alticor Chairman Steve Van Andel. "We've challenged our people around the world to focus on understanding and supporting the needs of consumers, and this year is a good first step toward that goal."
"Strong sales in 2007 mean more investment in innovation and performance in 2008," Alticor President Doug DeVos added. "We are determined to be more creative and responsive to the needs of the marketplace, and to gain ground in a very competitive direct selling industry."
Alticor operates primarily through Amway Corp., a global leader in direct selling founded in 1959; Quixtar Inc., a North American Web-based business opportunity launched in 1999; and Access Business Group LLC, a product development, manufacturing and logistics services provider to Amway, Quixtar, and other companies. In addition, Alticor is the parent of Alticor Corporate Enterprises, which develops and manages Alticor's non-directselling investments, including Amway Hotels Corp., Gurwitch Products, Interleukin Genetics and Fulton Innovation.
In 2007, Alticor announced that the Quixtar business in North America
will gradually transition to the Amway name. The company expects the
transition
'/>"/>
| SOURCE Alticor Inc. Copyright©2008 PR Newswire. All rights reserved |